Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT2: SPD476 (Lialda) for Prevention of Diverticulitis Recurrence
NCT00545103Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2007
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of Salcrozine in diverticulitis, sponsored by Takeda. Started Dec 2007; status: completed.
02
Drugs
Salcrozine
03
Conditions
diverticulitis
Beyond the preview
Go deeper on NCT00545103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545103.